A double-blind placebo-controlled trial of Rozerem [ramelteon] in migraine headaches.
Phase of Trial: Phase IV
Latest Information Update: 09 Feb 2012
At a glance
- Drugs Ramelteon (Primary)
- Indications Migraine
- Focus Therapeutic Use
- 09 Feb 2012 Last checked against ClinicalTrials.gov record.
- 09 Feb 2012 Actual patient number is 4 according to ClinicalTrials.gov.
- 09 Feb 2012 Status changed from completed to discontinued as reported by ClinicalTrials.gov.